Skincare company SkinCeuticals hosted press and practitioners to present its newly launched P-TIOX Cream and the next generation of PHYTO CORRECTIVE on July 14.
The morning opened with David McNulty-Ringshaw, regional sales manager south at SkinCeuticals, who introduced nurse practitioner Eleanor Hartley to the attendees. Hartley explored the P-TIOX Cream in detail, discussing its key ingredients, target patient demographics and commercial opportunities. She also outlined product-stacking strategies tailored to different treatment indications.
Holly Spencer, senior education and academy manager, then introduced the next generation of PHYTO CORRECTIVE, featuring biotechnological polydeoxyribonucleotide (PDRN). SkinCeuticals shares that it combines an 8% phytobotanical complex, including thyme, olive leaf and cucumber, with tripeptide-8 to help soothe the skin and reduce sensations of irritation; adding that the product has been tested for use alongside professional procedures, including microneedling, laser treatments and chemical peels.
Ollie Pearce, medical events and communications manager at SkinCeuticals, commented, “Launching P-TIOX Cream gave us the opportunity to bring practitioners together, not just introduce a product, with our power stack series reflecting SkinCeuticals’ continued investment in supporting and educating the aesthetic community across the UK and Ireland.”
